Franz Obermayr

Franz Obermayr, PhD

CEO

Panoptes Pharma

Biography

Dr. Franz Obermayr is Co-founder and serves as Chief Executive Officer of Panoptes.

Before that he was Head of Clinical Development at Nabriva Therapeutics developing a novel antibiotic agent.
Before that he held several positions at GPC-Biotech where he led development programs in Germany and US and played a key role in commercialization these programs with pharmaceutical companies.

Prior to GPC-Biotech he did his postdoctoral studies at the Max-Planck Institute for Immunobiology. Franz earned his PhD in Biochemistry at the Imperial Cancer Research Fund in London.

STAY UP TO DATE WITH OIS

STAY UP TO DATE WITH OIS

get the latest news & exclusive content!

get the latest news & exclusive content!